Neogen Chemicals Limited’s Board of Directors, in a meeting held on October 31, 2026, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting also saw the approval of various material related party transactions and an increase in the threshold for granting loans and investments up to ₹500 crore.
Financial Results Approved
Neogen Chemicals Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors, in their meeting on October 31, 2026, considered and approved these results, which have been reviewed by the Statutory Auditors and recommended by the Audit Committee.
Key Approvals and Transactions
The Board also approved an increase in the threshold for granting loans, ICDs, corporate guarantees, securities, and making investments in securities up to ₹500 crore under Section 186 of the Companies Act, 2013. This is subject to member approval.
Furthermore, several material related party transactions were considered and approved. These include transactions with Neogen Morita New Materials Limited (a step-down subsidiary) and Neogen Ionics Limited (a wholly owned subsidiary). These transactions, involving granting corporate guarantees, loans, and other services, are proposed to be entered into during the period from December 8, 2026, to December 7, 2027, and require member approval.
An update on the voluntary early redemption of outstanding non-convertible debentures (NCDs) was also noted. The company is also expanding its Organo-Lithium chemicals manufacturing facility, with an estimated investment of up to ₹45 crore.
A Postal Ballot notice was approved to seek shareholder approval for the material related party transactions. The e-voting process is scheduled to commence on November 7, 2026, and conclude on December 6, 2026.
Source: BSE
